Nil Molinas Mandel
Cuban-developed cancer vaccine tested on 39 cancer patients in Turkey
A Cuban-developed cancer vaccine that is not licensed in any country other than Argentina is now being tested on 39 cancer patients in five different health centers in Turkey.
Although not a cure, the drug named Racotumomab has been shown in previous clinical trials conducted in Argentina and Cuba to extend survival about two to three months on average.